NCT07598825 A Trial of Inebilizumab in Participants With Autoimmune Hepatitis Status NOT_YET_RECRUITING Phase PHASE3
NCT07590193 A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus Status NOT_YET_RECRUITING Phase PHASE1
NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) Status NOT_YET_RECRUITING Phase PHASE3
NCT07545226 Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose. Status NOT_YET_RECRUITING Phase PHASE1
NCT07531095 Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) Status RECRUITING Phase PHASE1
NCT07526298 Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients Status NOT_YET_RECRUITING Phase N/A
NCT07523711 Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity Status RECRUITING Phase PHASE1
NCT07493512 Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT07478887 Impact of the Corrie Lipids Digital Health Program on Lipid Optimization Status RECRUITING Phase NA
NCT07441252 A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight Status RECRUITING Phase PHASE2
NCT07438405 An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease Status NOT_YET_RECRUITING Phase PHASE2
NCT07429045 A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body Status COMPLETED Phase PHASE1
NCT07428525 A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT07423585 Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer Status RECRUITING Phase PHASE2
NCT07422285 Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose Status RECRUITING Phase PHASE1
NCT07403721 AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors Status RECRUITING Phase PHASE1
NCT07388498 A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout Status RECRUITING Phase PHASE3
NCT07366086 Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta Status RECRUITING Phase PHASE3